Page last updated: 2024-08-22

cadmium and Leukemia, Myeloid, Acute

cadmium has been researched along with Leukemia, Myeloid, Acute in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's0 (0.00)24.3611
2020's1 (50.00)2.80

Authors

AuthorsStudies
Wan, XM; Zheng, C; Zhou, XL1
Angel, CR; Bishop, MR; Iversen, PL; Mata, JE; Swanson, SA; Tarantolo, SR1

Trials

1 trial(s) available for cadmium and Leukemia, Myeloid, Acute

ArticleYear
Evidence of enhanced iron excretion during systemic phosphorothioate oligodeoxynucleotide treatment.
    Journal of toxicology. Clinical toxicology, 2000, Volume: 38, Issue:4

    Topics: Cadmium; Chelating Agents; Copper; Dose-Response Relationship, Drug; Erythrocyte Count; Humans; Infusions, Intravenous; Iron; Iron Chelating Agents; Leukemia, Myeloid, Acute; Male; Metabolic Clearance Rate; Middle Aged; Myelodysplastic Syndromes; Oligodeoxyribonucleotides, Antisense; RNA, Messenger; Spectrophotometry, Atomic; Thionucleotides; Tumor Suppressor Protein p53; Zinc

2000

Other Studies

1 other study(ies) available for cadmium and Leukemia, Myeloid, Acute

ArticleYear
Puerarin prevents cadmium-induced mitochondrial fission in AML-12 cells via Sirt1-dependent pathway.
    Ecotoxicology and environmental safety, 2022, Dec-15, Volume: 248

    Topics: Animals; Cadmium; Leukemia, Myeloid, Acute; Mice; Mitochondrial Dynamics; Sirtuin 1

2022